CABA
Price
$1.84
Change
+$0.03 (+1.66%)
Updated
Sep 12 closing price
Capitalization
165.55M
60 days until earnings call
TRML
Price
$47.61
Change
+$0.01 (+0.02%)
Updated
Sep 12 closing price
Capitalization
1.22B
Interact to see
Advertisement

CABA vs TRML

Header iconCABA vs TRML Comparison
Open Charts CABA vs TRMLBanner chart's image
Cabaletta Bio
Price$1.84
Change+$0.03 (+1.66%)
Volume$1.58M
Capitalization165.55M
Tourmaline Bio
Price$47.61
Change+$0.01 (+0.02%)
Volume$988.51K
Capitalization1.22B
CABA vs TRML Comparison Chart in %
Loading...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CABA vs. TRML commentary
Sep 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CABA is a Hold and TRML is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 13, 2025
Stock price -- (CABA: $1.84 vs. TRML: $47.61)
Brand notoriety: CABA and TRML are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CABA: 121% vs. TRML: 125%
Market capitalization -- CABA: $165.55M vs. TRML: $1.22B
CABA [@Biotechnology] is valued at $165.55M. TRML’s [@Biotechnology] market capitalization is $1.22B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.15B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CABA’s FA Score shows that 0 FA rating(s) are green whileTRML’s FA Score has 0 green FA rating(s).

  • CABA’s FA Score: 0 green, 5 red.
  • TRML’s FA Score: 0 green, 5 red.
According to our system of comparison, both CABA and TRML are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CABA’s TA Score shows that 6 TA indicator(s) are bullish while TRML’s TA Score has 5 bullish TA indicator(s).

  • CABA’s TA Score: 6 bullish, 4 bearish.
  • TRML’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both CABA and TRML are a good buy in the short-term.

Price Growth

CABA (@Biotechnology) experienced а +8.24% price change this week, while TRML (@Biotechnology) price change was +78.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.38%. For the same industry, the average monthly price growth was +7.84%, and the average quarterly price growth was +35.14%.

Reported Earning Dates

CABA is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+1.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRML($1.22B) has a higher market cap than CABA($166M). TRML YTD gains are higher at: 134.763 vs. CABA (-18.943). TRML has higher annual earnings (EBITDA): -102.41M vs. CABA (-140.83M). TRML has more cash in the bank: 239M vs. CABA (195M). TRML has less debt than CABA: TRML (145K) vs CABA (24.9M). CABA (0) and TRML (0) have equivalent revenues.
CABATRMLCABA / TRML
Capitalization166M1.22B14%
EBITDA-140.83M-102.41M138%
Gain YTD-18.943134.763-14%
P/E RatioN/AN/A-
Revenue00-
Total Cash195M239M82%
Total Debt24.9M145K17,172%
FUNDAMENTALS RATINGS
CABA: Fundamental Ratings
CABA
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CABATRML
RSI
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 5 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DHSIX26.00N/A
N/A
Diamond Hill Small Cap I
JAGTX74.58N/A
N/A
Janus Henderson Glb Tech and Innovt T
USLYX70.40N/A
N/A
JHancock U.S. Global Leaders Growth R2
BCSKX9.69N/A
N/A
BlackRock Commodity Strategies K
FMSRX17.38N/A
N/A
Frontier MFG Global Sustainable Svc

CABA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CABA has been loosely correlated with IPSC. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
+1.66%
IPSC - CABA
52%
Loosely correlated
-3.38%
ARWR - CABA
47%
Loosely correlated
N/A
GBIO - CABA
47%
Loosely correlated
-1.33%
PYXS - CABA
45%
Loosely correlated
-2.15%
KYTX - CABA
45%
Loosely correlated
-5.54%
More